Thyroid Gland Medullary Carcinoma

specific

A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and al

45

Centers

42

Active Trials

Cancer Funding

Top Centers for Thyroid Gland Medullary Carcinoma(45)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.6
2
NCI Comprehensive
Active Research Program
52.6
3
NCI Comprehensive
Active Research Program
52.6
4
NCI Comprehensive
Active Research Program
52.6
5
NCI Comprehensive
Active Research Program
52.6
6
NCI Comprehensive
Active Research Program
52.6
7
NCI Comprehensive
Active Research Program
52.6
8
NCI Comprehensive
Active Research Program
52.6
9
NCI Comprehensive
Active Research Program
52.6
10
NCI Comprehensive
Active Research Program
52.6
11
NCI Comprehensive
Active Research Program
52.6
12
NCI Comprehensive
Active Research Program
52.6
13
NCI Comprehensive
Active Research Program
52.6
14
NCI Comprehensive
Active Research Program
52.6
1552.6
16
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
52.6
17
NCI Comprehensive
Active Research Program
52.6
18
NCI Comprehensive
Active Research Program
52.6
19
NCI Comprehensive
Active Research Program
52.6
20
NCI Clinical
Active Research Program
52.6
21
NCI Comprehensive
Active Research Program
52.6
22
NCI Comprehensive
Active Research Program
52.6
23
NCI Clinical
Active Research Program
52.6
24
Active Research Program
52.6
25
Active Research Program
52.6
26
NCI Comprehensive
Active Research Program
52.6
27
NCI Clinical
Active Research Program
52.6
28
NCI Comprehensive
Active Research Program
52.6
29
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.6
30
Active Research Program
52.6
31
NCI Clinical
Active Research Program
52.6
32
Active Research Program
52.6
33
Active Research Program
52.6
34
NCI Comprehensive
Active Research Program
52.6
3552.6
36
Active Research Program
52.6
37
Active Research Program
52.6
38
Active Research Program
52.6
39
Active Research Program
52.6
40
Active Research Program
52.6
41
Active Research Program
52.6
42
Active Research Program
52.6
43
NCI Comprehensive
30.1
44
NCI Comprehensive
30.1
45
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
30.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →